You are here: Industry Insights > Diabetes

News List

Gan & Lee Announces New Partnership with International Diabetes Federation prnasia
February 22, 2021
Gan & Lee Pharmaceuticals Co., Ltd. has announced a collaborative partnership with the International Diabetes Federation (IDF) that aims to support their global efforts of promoting diabetes care and prevention worldwide.
Metavention Initiates Trial for Novel Treatment of Type 2 Diabetes americanpharmaceuticalreview
February 20, 2021
Metavention announced the initiation of an U.S. Food and Drug Administration (FDA) approved clinical investigation, DeLIVER, for the Company's intravascular iRF Denervation System to determine safety in patients with type 2 diabetes (T2D).
Biocon Biologics partners with IDF to improve access to insulins expresspharma
February 18, 2021
Biocon Biologics, a subsidiary of Biocon, has announced a partnership with the International Diabetes Federation (IDF) to promote and support IDF’s Core Mission initiative and activities.
UK researchers find semaglutide could be a ‘game changer’ drug to fight obesity expresspharma
February 18, 2021
The drug, semaglutide, works by hijacking the body's own appetite-regulating system in the brain leading to reduced hunger and calorie intake, according to the study.
ViaCyte Announces Initiation of Encapsulated Cell Therapy Study for Type 1 Diabetes americanpharmaceuticalreview
February 08, 2021
ViaCyte announced that the first type 1 diabetes (T1D) patients have been implanted in a Phase 2 clinical study utilizing encapsulated delivery of cells.
Creative Medical Technology Announces Positive Data Using ImmCelz to Treat Type 1 Diabetes americanpharmaceuticalreview
January 20, 2021
Creative Medical Technology Holdings announced positive data and filing of a patent application covering the use of ImmCelz® in prevention and regression of type 1 diabetes.
Metformin use reduces risk of death for patients with COVID-19 and diabetes worldpharmanews
January 19, 2021
Use of the diabetes drug metformin - before a diagnosis of COVID-19 - is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham ...
Lupin gets tentative USFDA nod for empagliflozin and metformin hydrochloride ER tablets expresspharma
January 08, 2021
They are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus.
New process for producing synthetic insulin developed europeanpharmaceuticalreview
January 07, 2021
Researchers say that their novel way to produce synthetic insulin could also be used to create at least eight other drugs.
Glenmark launches Remogliflozin + Vildagliptin FDC in India to treat Type 2 diabetes expresspharma
December 30, 2020
The FDC will be marketed under two brand names Remo V and Remozen V priced at Rs 14 per tab and Rs 28 per day cost of therapy.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page